Skip to main content
. 2021 Sep 28;29(2):1076–1084. doi: 10.1245/s10434-021-10847-9

Fig. 2.

Fig. 2.

Best practice work flow for the use of vacuum-assisted biopsy after neoadjuvant systemic treatment to reliably rule out residual disease. DCIS ductal carcinoma in situ; NST neoadjuvant systemic treatment; VAB vacuum-assisted biopsy